ARCHIVES

DRCCA Board Okays Chemoprevention RFA, Referral Guidelines

This article is from The Cancer Letter archive.

Vol. 08 No. 05 | January 29, 1982

Download PDF Visit The Full Archive

Related Articles

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Kennedy Chooses Health/Education Chair Over Judiciary; No Major Changes In Senate Cancer Policies Expected

November 14, 1986

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

Q&A With The Cancer Letter: MD Anderson Provost Had No Say

May 25, 2012

Emerging Technologies: Company To Expand Program Studying Polymer Platinates

June 1, 2001

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013